医学
慢性淋巴细胞白血病
耐火材料(行星科学)
酪氨酸激酶抑制剂
肿瘤科
内科学
伊布替尼
白血病
癌症
天体生物学
物理
作者
Samuel Crawford,Huimin Li,Bhavini Srivastava,Pam Martin,J.C. Gahn,Shaffee Bacchus,Olga Ryan,Monika Salkar
出处
期刊:Journal of The National Comprehensive Cancer Network
日期:2025-03-28
卷期号:23 (3.5)
标识
DOI:10.6004/jnccn.2024.7351
摘要
"HSR25-203: Cost-Effectiveness Evaluation of Bruton Tyrosine Kinase Inhibitor (BTKi) Treatments Among Medicare Patients With Chronic Lymphocytic Leukemia (CLL) in First-Line (1L) and Relapsed/Refractory (R/R) Settings" published on 28 Mar 2025 by National Comprehensive Cancer Network.
科研通智能强力驱动
Strongly Powered by AbleSci AI